OpenBilldrug price receipt

NADAC week of 2026-10-14

OLMESARTAN MEDOXOMIL 20 MG TAB

For 30 tablets

Pharmacies pay

$2.41 filed

30 × $0.08049 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$7.71 filed

30 × $0.25694 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

3.2× estimated

Medicare paid 3.2× what pharmacies pay.

Part D averages every strength and form sold under “Olmesartan Medoxomil” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$7.77 estimated

$2.41 + $0.36 (15%) + $5.00 fee per fill = $7.77

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

OLMESARTAN MEDOXOMIL 20 MG TAB is how the CMS NADAC file names this product. The FDA NDC Directory lists it as olmesartan medoxomil.

FDA gives its dosage form as “tablet, film coated”, “tablet” and “tablet, coated” and its route as oral.

FDA lists 15 labelers (the companies named on the label) for its NDCs, among them Lannett Company, Inc., Camber Pharmaceuticals, Inc. and Macleods Pharmaceuticals Limited.

FDA’s Established Pharmacologic Class for it is Angiotensin 2 Receptor Blocker.

The NADAC file of 2026-10-14 prices it under 29 NDCs (National Drug Codes).

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $2.41 for 30 tablets (30 × $0.08049 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

The 15 labelers

LabelerNDCsPharmacies pay per unit
Novadoz Pharmaceuticals LLC3$0.08049 per EA filed
ScieGen Pharmaceuticals, Inc.3$0.08049 per EA filed
Alembic Pharmaceuticals Inc.2$0.08049 per EA filed
Ascend Laboratories, LLC2$0.08049 per EA filed
Aurobindo Pharma Limited2$0.08049 per EA filed
Camber Pharmaceuticals, Inc.2$0.08049 per EA filed
Glenmark Pharmaceuticals Inc., USA2$0.08049 per EA filed
HEC Pharm USA Inc.2$0.08049 per EA filed
Jubilant Cadista Pharmacuticals Inc.2$0.08049 per EA filed
Lannett Company, Inc.2$0.08049 per EA filed
Rising Pharma Holdings, Inc.2$0.08049 per EA filed
Solco Healthcare US, LLC.2$0.08049 per EA filed
Macleods Pharmaceuticals Limited1$0.08049 per EA filed
Modavar Pharmaceuticals LLC1$0.08049 per EA filed
QUALLENT PHARMACEUTICALS HEALTH LLC1$0.08049 per EA filed
All 29 NDCs, with labeler and price
  • 00527-2426-32 · Lannett Company, Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 00527-2426-46 · Lannett Company, Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 31722-0853-30 · Camber Pharmaceuticals, Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 31722-0853-90 · Camber Pharmaceuticals, Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 33342-0179-10 · Macleods Pharmaceuticals Limited · $0.08049 per EA · eff. 2026-09-23 filed
  • 43547-0300-03 · Solco Healthcare US, LLC. · $0.08049 per EA · eff. 2026-09-23 filed
  • 43547-0300-09 · Solco Healthcare US, LLC. · $0.08049 per EA · eff. 2026-09-23 filed
  • 50228-0340-10 · ScieGen Pharmaceuticals, Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 50228-0340-30 · ScieGen Pharmaceuticals, Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 50228-0340-90 · ScieGen Pharmaceuticals, Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 59746-0465-30 · Jubilant Cadista Pharmacuticals Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 59746-0465-90 · Jubilant Cadista Pharmacuticals Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 62332-0132-30 · Alembic Pharmaceuticals Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 62332-0132-90 · Alembic Pharmaceuticals Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 64980-0602-03 · Rising Pharma Holdings, Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 64980-0602-09 · Rising Pharma Holdings, Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 65862-0742-30 · Aurobindo Pharma Limited · $0.08049 per EA · eff. 2026-09-23 filed
  • 65862-0742-90 · Aurobindo Pharma Limited · $0.08049 per EA · eff. 2026-09-23 filed
  • 67877-0446-30 · Ascend Laboratories, LLC · $0.08049 per EA · eff. 2026-09-23 filed
  • 67877-0446-90 · Ascend Laboratories, LLC · $0.08049 per EA · eff. 2026-09-23 filed
  • 68462-0437-30 · Glenmark Pharmaceuticals Inc., USA · $0.08049 per EA · eff. 2026-09-23 filed
  • 68462-0437-90 · Glenmark Pharmaceuticals Inc., USA · $0.08049 per EA · eff. 2026-09-23 filed
  • 72205-0166-30 · Novadoz Pharmaceuticals LLC · $0.08049 per EA · eff. 2026-09-23 filed
  • 72205-0166-66 · Novadoz Pharmaceuticals LLC · $0.08049 per EA · eff. 2026-09-23 filed
  • 72205-0166-90 · Novadoz Pharmaceuticals LLC · $0.08049 per EA · eff. 2026-09-23 filed
  • 72241-0079-04 · Modavar Pharmaceuticals LLC · $0.08049 per EA · eff. 2026-09-23 filed
  • 72303-0849-01 · HEC Pharm USA Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 72303-0849-02 · HEC Pharm USA Inc. · $0.08049 per EA · eff. 2026-09-23 filed
  • 82009-0074-90 · QUALLENT PHARMACEUTICALS HEALTH LLC · $0.08049 per EA · eff. 2026-09-23 filed

Other strengths, forms and brands

5 other products in the NADAC file share the FDA nonproprietary name olmesartan medoxomil with OLMESARTAN MEDOXOMIL 20 MG TAB.

ProductPharmacies pay per unitMedicare per unit
BENICAR 5 MG TABLET
brand · tablet, film coated
$10.1271 per EA filed
eff. 2026-07-01
$11.29735 per EA filed
Part D 2024 average
BENICAR 20 MG TABLET
brand · tablet, film coated
$12.31644 per EA filed
eff. 2026-07-01
$11.29735 per EA filed
Part D 2024 average
BENICAR 40 MG TABLET
brand · tablet, film coated
$17.24162 per EA filed
eff. 2026-07-01
$11.29735 per EA filed
Part D 2024 average
OLMESARTAN MEDOXOMIL 5 MG TAB
generic · tablet, film coated / tablet / tablet, coated
$0.05748 per EA filed
eff. 2026-09-23
$0.25694 per EA filed
Part D 2024 average
OLMESARTAN MEDOXOMIL 20 MG TAB this page
generic · tablet, film coated / tablet / tablet, coated
$0.08049 per EA filed
eff. 2026-09-23
$0.25694 per EA filed
Part D 2024 average
OLMESARTAN MEDOXOMIL 40 MG TAB
generic · tablet, film coated / tablet / tablet, coated
$0.11097 per EA filed
eff. 2026-09-23
$0.25694 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-07-01, 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

Compared with its class

The middle of its 29 NDCs’ NADAC prices is $0.08049 per EA filed.

Of the 107 other products in FDA’s Angiotensin 2 Receptor Blocker class priced per EA, 100 have a higher middle NADAC price and 7 a lower one. The one in the middle is OLMSRTN-AMLDPN-HYDROCHLOROTHIAZIDE 40-10-12.5, at $1.15137 per EA filed (eff. 2026-09-23).

Prices are compared per unit, whatever the strength or dose, and a class is not a list of substitutes.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

What Medicare paid

Medicare Part D paid $7.71 for 30 tablets, at an average of $0.25694 per EA in 2024 (2024-01-01 to 2024-12-31) for “Olmesartan Medoxomil”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 3,499,458 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for OLMESARTAN MEDOXOMIL 20 MG TAB labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Olmesartan Medoxomil / Olmesartan Medoxomil: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on generic name.